Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

meeting   source : Www.nantkwest.com    save search

First Data for ImmunityBio’s Memory Cytokine-Enriched NK Cells in Small Cell Lung Cancer at SITC Meeting Show Promising Anti-tumor Activity
Published: 2023-11-07 (Crawled : 15:00) - nantkwest.com
IBRX | $5.265 7.23% 6.74% 4.6M twitter stocktwits trandingview |
Manufacturing
| | O: -0.83% H: 3.92% C: 1.68%

lung cancer cell meeting show
ImmunityBio Announces Presentation at ASCO GI 2023 of Fully Enrolled Trial in Third-Line and Greater Pancreatic Cancer and Update on FDA Type B Meetings Regarding Paths to Registration
Published: 2023-01-19 (Crawled : 14:20) - nantkwest.com
IBRX | $5.265 7.23% 6.74% 4.6M twitter stocktwits trandingview |
Manufacturing
| | O: -1.1% H: 1.11% C: 0.22%

fda trial presentation asco update cancer pancreatic
ImmunityBio Announces QUILT Trial Results for BCG-Unresponsive Bladder Cancer and Advanced Metastatic Pancreatic Cancer at the 2022 American Society of Clinical Oncology Annual Meeting
Published: 2022-06-06 (Crawled : 13:00) - nantkwest.com
FNCTF | News | $11.0354 -20.84% 320 twitter stocktwits trandingview |
Communications
| | O: 0.17% H: 0.0% C: 0.0%
IBRX | $5.265 7.23% 6.74% 4.6M twitter stocktwits trandingview |
Manufacturing
| | O: 14.42% H: 1.88% C: -4.29%

trial cancer pancreatic bladder
ImmunityBio To Present Data From Multiple Clinical Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-28 (Crawled : 13:00) - nantkwest.com
IBRX | $5.265 7.23% 6.74% 4.6M twitter stocktwits trandingview |
Manufacturing
| | O: -0.13% H: 3.05% C: -0.8%

trials
ImmunityBio Announces Oral Presentation of Phase 2/3 Clinical Trial Results of Patients with BCG-Unresponsive Bladder Cancer Carcinoma at the Upcoming American Urological Association’s Annual Meeting
Published: 2021-09-01 (Crawled : 13:00) - nantkwest.com
IBRX | $5.265 7.23% 6.74% 4.6M twitter stocktwits trandingview |
Manufacturing
| | O: 0.97% H: 3.13% C: 2.7%

presentation phase 2 phase 2/3 results cancer trial trial results bladder
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.